Loading...
Loading...
STIM| Name | Value |
|---|---|
| Revenues | 15.5M |
| Cost of Revenue | 4.1M |
| Gross Profit | 11.4M |
| Operating Expense | 21.3M |
| Operating I/L | -9.9M |
| Other Income/Expense | -0.6M |
| Interest Income | 0.6M |
| Pretax | -10.5M |
| Income Tax Expense | 0.6M |
| Net Income/Loss | -11.1M |
Neuronetics, Inc. is a medical technology company that designs, develops, and markets the NeuroStar Advanced Therapy System, a non-invasive treatment for adult patients with major depressive disorder. The system uses transcranial magnetic stimulation to induce electrical currents in specific areas of the brain associated with mood. Neuronetics sells its products through a dedicated sales and customer support team to psychiatrists, generating revenue from the sale of the NeuroStar Advanced Therapy System and related services.
